DEUTSCHE BANK AG\ - AXOVANT GENE THERAPIES LTD ownership

AXOVANT GENE THERAPIES LTD's ticker is AXGT and the CUSIP is G0750W203. A total of 50 filers reported holding AXOVANT GENE THERAPIES LTD in Q4 2019. The put-call ratio across all filers is 0.38 and the average weighting 0.0%.

Quarter-by-quarter ownership
DEUTSCHE BANK AG\ ownership history of AXOVANT GENE THERAPIES LTD
ValueSharesWeighting
Q4 2019$070.0%0.00%
Q3 2019$0
-100.0%
7
-99.6%
0.00%
Q2 2019$11,0001,7760.00%
Other shareholders

There were no reported owners of AXOVANT GENE THERAPIES LTD in Q4 2019.

NameSharesValueWeighting ↓
View complete list of AXOVANT GENE THERAPIES LTD shareholders